Programme

Friday, June 14th

08:30-09:00 am

Delivery of documentation.

09:00-09:15 am

Opening.

09:15-10:00 am

Symposium 1. Living positive: The effectiveness and implementation of a guided online intervention for people with HIV and depressive symptoms.

Moderators: Guida da Ponte – Andrea Calcagno.
Sanne Van Luenen – Vivian Kraaij.

10:00-10:45 am

Symposium 2. A mobile app to screen for neurocognitive impairment HIV.

Moderators: Scott Letendre – José A. Muñoz-Moreno.
Reuben Robbins.

10:45-11:30 am

Coffee Break 

11:30-11:50 am

Understanding the role of patient reported outcomes in the management of HIV.
Moderators: Jordi Blanch – Esteban Martínez.
Antonella Cingolani.

 

11:50-01:00 pm

Oral Communications 1. 

Moderator: Paola Cinque.

1.1 – Relevance of the QPC Cognitive complaints questionnaire as a guiding tool in the screening strategy for HIV‐associated neurocognitive disorders. 

Olivia Zaegel-Faucher.

1.2 – Resting EEG‐LORETA and CSF Biomarkers in Patients with HAND.

Alessandro Lazaro.

1.3 – Exploring the Association Between the Route of HIV Acquisition and the Different Patterns of Neurocognitive Impairment. 

Giulia de Zan.

1.4 – Remarkable Accuracy of the NEU Screen Detecting Cognitive Impairment in Aging People Living with HIV/AIDS.

José A Muñoz-Moreno.

1.5 – A Example of comprehensive neurocognitive assessment in a HIV population in Northern Italy.

Cesare Bolla.

1.6 – No evidence of neuro‐axonal injury following latency reversal with vorinostat and HIV‐specific vaccination in the RIVER trial.

Jasmini Alagaratnam.

01:00-02:00 pm

Lunchtime. 

02:00-02:45 pm

Symposium 3.  Prevalence of mental health problems among people living with HIV.

Moderators: Amnemiek Schadé – Alan Winston.
Fiona Lampe.

02:45-05:45 pm

Workshops. Session without simultaneous translation.
1. Substance use:

– Scope of the problem: Ignacio Pérez-Valero.
– Prevention: Milton Wainberg.
– Screening and diagnosis: Guida da Ponte.
– Treatment: Amnemiek Schadé.
Moderator: Jordi Blanch.

2. Neurocognitive diagnostic methods:

– Clinical diagnosis: when neurocognitive impairment should be suspected?. Scott Letendre.
– NP tests: which, when, and how?. José A. Muñoz-Moreno.
– Imaging: which procedures and how they can help?. Alan Winston. 
– What can we expect from biomarkers?. Paola Cinque.
– How to assess neurotoxicity?.  Andrea Calcagno.
Moderators: Daniel Podzamczer and Esteban Martínez.

Presentation of 10-15 min. for each topic and 45-60 minutes of discussion with questions about screening, diagnostic, prevention and treatment.

Saturday, June 15th

09:00-10:00 am

Case Studies.

Moderator: Alan Winston.
Brendan Payne – Monica Calado Marta.  

10:00-10:30 am

Coffee  Break 

10:30-11:30 am

Oral Communications. Session 2.

Moderator: Milton Wainberg.

2.1 – Retention in HIV care guidelines: Addressing comorbidity to achieve UNAIDS 90-90-90 targets.

Shiraze Bulsara.

2.2 – Psychological adjustment to Human Inmmunodeficiency Virus (HIV) and psychosocial associated factors.

Carmen Vicioso.

2.3 – A multidisciplinary approach between Consultation‐Liaison Psychiatry and HIV clinics in Portugal.

Guida da Ponte.

2.4 – HIV mental health care: a stepped care model to improve quality of life in people living with HIV.

Hendrik van Gorsel.

2.5 – Factors related to willingness to use PrEP among men who have sex with men from an HIV clinic in Mexico City.

Hamid Vega-Ramirez.

2.6 – Using Syndemic Theory to understand the ChemSex practice from the narratives of a group of gay and bisexual men in Barcelona city.

Percy Fernández Dávila.

11:30-12:15 pm

Symposium 4. Hot topics on CNS and HIV. 

Moderator: Esteban Martínez

Scott Letendre. 

12:15-01:15 pm

Special lecture. New insights into the pathophysiology of major depressive disorder.

Moderator: Jordi Blanch.
Francesc Artigas.   

01:15-01:30 pm

Closure and Farewell.

Download Programme PDF

View Speakers